Related references
Note: Only part of the references are listed.Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
Judit Ribas et al.
CANCER RESEARCH (2009)
Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer
Rafael Rosell et al.
CLINICAL LUNG CANCER (2009)
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer
Tomasz M. Beer et al.
CANCER (2008)
EAU guidelines on prostate cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
Aaron J. Schetter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
MicroRNA involvement in hepatocellular carcinoma
Laura Gramantieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
Zhiyu Zhang et al.
LABORATORY INVESTIGATION (2008)
MicroRNA in Cancer Prognosis
Frank J. Slack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Z. Lu et al.
ONCOGENE (2008)
Serum MicroRNAs Are Promising Novel Biomarkers
Shlomit Gilad et al.
PLOS ONE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells
Lisa B. Frankel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients
S. Oudard et al.
ANNALS OF ONCOLOGY (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
Docetaxel plus prednisone versus mitoxantrone plus prednisone for metastatic hormone-refractory prostate cancer in chinese patients: Experience of a single center
Hai Liang Zhang et al.
UROLOGIA INTERNATIONALIS (2007)
Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy
Tateki Yoshino et al.
CLINICAL CANCER RESEARCH (2006)
Management of prostate cancer in China:: A multicenter report of 6 institutions
M Peyromaure et al.
JOURNAL OF UROLOGY (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Cancer incidence and mortality in Europe, 2004
P Boyle et al.
ANNALS OF ONCOLOGY (2005)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons
M Quinn et al.
BJU INTERNATIONAL (2002)
Share Paper
